Table 2.
No. | Compound Structure | SARS CoV-2 3CLpro IC50 (µM) |
SARS-CoV-2 EC50 (µM) a |
---|---|---|---|
1 | 3.47 | >100 | |
2 | 17.1 | 63.7 | |
3 | 0.65 | >100 | |
4 | 4.9 | 23.8 | |
5 | 0.54 | >100 | |
6 | 1.4 | >100 | |
7 | 0.39 | 46.3 | |
8 | 0.74 | 48.3 | |
9 | 3.73 | >100 | |
10 | 4.26 | >100 | |
11 | 15.4 | >100 | |
12 | 107.8 | >100 | |
13 | 1.11 | >100 | |
14 | 1.51 | >100 |
a Compounds 3 and 5 exhibited antiviral EC50 values of 2.8 and 2.4 μm, respectively.